Early evidence suggests CBD could help clinicians treat pericarditis, myocarditis and other significant heart conditions. Additional research is still required, however, including many more clinical trials.

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.

A veteran cardiologist is back on the job after reportedly being fired for his participation in a controversial CDC panel. His wife shared the update, saying they were "truly humbled" by everyone who came to his defense.

Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy. 

This update helps health systems get more value out of UltraSight's advanced AI technology—all without buying brand new ultrasound equipment.

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider. 

Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.  

According to Gore, the newly approved device was built with conformability, strength and fracture resistance in mind. 

Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

These most recent recalls focus on a series of maintenance issues. In 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options.

ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.

San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

If you still think of large-language AI as a newish thing yet to catch on with healthcare consumers, think again.

Timesha Beauchamp, 20, suffered a seizure in August 2020 that required emergency medical attention. When responders arrived, they declared her dead at the scene. A short time later, she was found to be alive at a funeral parlor. More than five years later, a lawsuit stemming from the incident has been settled out of court.